Valuation
- Market cap
- 345,000
- Revenue TTM
- $0
- Net income TTM
- $2,380,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- -0.14
Trading
- Volume
- 100
- Avg volume
- 67,512
- Day's range
- $0.01 – $0.01
- Shares out
- 49,332,000
- Stochastic %K
- 6%
- Beta
- 2.92
- Analysts
- —
- Price target
- —
Company profile
NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered...
Show more
NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida.
- Industry
- Diagnostics & Research
- Sector
- Healthcare
- Phone
- 410 598 9024
- Website
- https://www.novelstem.com
- Address
- 2255 Glades Road, Suite 221A, Boca Raton, United States
Latest news
No headlines yet.
